Document is current
Any future updates will be listed below
-
Authors
Bjørn-Yoshimoto, Walden E.
Ramiro, Iris Bea L.
Koch, Thomas Lund
Engholm, Ebbe
Yeung, Ho Yan
Sørensen, Kasper K.
Goddard, Carolyn M.
Jensen, Kathrine L.
Smith, Nicholas A.
Martin, Laurent F.
Smith, Brian J.
Madsen, Kenneth L.
Jensen, Knud J.
Patwardhan, Amol
Safavi-Hemami, Helena
-
Funding
Funding for this research was provided by:
Lundbeck Foundation (R400-2022-509)
Lundbeck Foundation (R322-2019-1816)
Lundbeck Foundation (R344-2020-106)
Danmarks Frie Forskningsfond (3102-00006)
NIH (R01NS116694)
Villum Fonden (19063)
- License Information
-
More Information
Article History
Received: 9 September 2025
Accepted: 30 October 2025
First Online: 28 November 2025
Declarations
:
: WEB, IBLR, TLK, and HSH are inventors of a patent application for Fj1 and its analogs (patent application # WO2023180125A1) and WEB and HSH are co-founders of a company focused on the development of novel SSTR4-targeting pain therapeutics.
